Data Insights
By Company Name
No Filter Selected
By Disease Name
No Filter Selected
By Drug Name
No Filter Selected
By Themes
No Filter Selected
Showing 2 results out of 2
Data Insights
HZB-0071 by Heilongjiang ZBD Pharmaceutical for Gastric Cancer: Likelihood of Approval
HZB-0071 is under clinical development by Heilongjiang ZBD Pharmaceutical and currently in Phase I for Gastric Cancer. According to GlobalData,...
Data Insights
HZB-0071 by Heilongjiang ZBD Pharmaceutical for Adenocarcinoma: Likelihood of Approval
HZB-0071 is under clinical development by Heilongjiang ZBD Pharmaceutical and currently in Phase I for Adenocarcinoma. According to GlobalData, Phase...